Abstract
Preliminary Outcome of Desensitization With Super High Dose IVIG, Plasmapheresis, and Rituximab for Crossmatch-Positive (Highly Sensitized) Kidney Transplant Recipients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have